|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
increases transport multiple interactions |
ISO |
ABCB1 protein results in increased transport of Quinacrine Elacridar inhibits the reaction [ABCB1 protein results in increased transport of Quinacrine] |
CTD |
PMID:16581945 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions |
ISO |
Quinacrine results in decreased activity of and results in increased phosphorylation of ACACA protein |
CTD |
PMID:35724837 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
ISO |
Quinacrine inhibits the reaction [AGT protein results in increased metabolism of and results in increased abundance of Arachidonic Acid] |
CTD |
PMID:16257180 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases response to substance multiple interactions increases expression |
ISO |
BAX protein results in increased susceptibility to Quinacrine 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of BAX mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of BAX protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of BAX protein]; mithramycin A inhibits the reaction [Quinacrine results in increased expression of BAX mRNA]; mithramycin A inhibits the reaction [Quinacrine results in increased expression of BAX protein]; Quinacrine promotes the reaction [SP1 protein binds to BAX promoter]; Quinacrine results in increased expression of and affects the localization of BAX protein |
CTD |
PMID:16177561 PMID:28867437 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Btrc |
beta-transducin repeat containing E3 ubiquitin protein ligase |
decreases expression multiple interactions |
ISO |
Quinacrine results in decreased expression of BTRC protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in decreased expression of BTRC protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of BAX protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of SP1 protein]; FOXP3 protein affects the reaction [Quinacrine results in decreased expression of BTRC protein]; MIR183 mRNA affects the reaction [Quinacrine results in decreased expression of BTRC protein]; Quinacrine results in decreased expression of and results in decreased stability of BTRC mRNA |
CTD |
PMID:28867437 |
|
NCBI chr 1:244,210,299...244,380,126
Ensembl chr 1:244,210,314...244,376,721
|
|
G |
Casp3 |
caspase 3 |
increases cleavage increases activity multiple interactions |
ISO |
Quinacrine results in increased cleavage of CASP3 protein Quinacrine results in increased activity of CASP3 protein GSK3B protein affects the reaction [Quinacrine results in increased activity of CASP3 protein] |
CTD |
PMID:28720477 PMID:28867437 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases cleavage |
ISO |
Quinacrine results in increased cleavage of CASP9 protein |
CTD |
PMID:28867437 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression multiple interactions |
ISO |
Quinacrine results in decreased expression of CCND1 protein GSK3B protein affects the reaction [Quinacrine results in decreased expression of CCND1 protein] |
CTD |
PMID:28720477 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
Quinacrine results in decreased expression of CDKN1A mRNA |
CTD |
PMID:32910239 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Csnk1a1 |
casein kinase 1, alpha 1 |
increases expression multiple interactions |
ISO |
Quinacrine results in increased expression of CSNK1A1 protein GSK3B protein affects the reaction [Quinacrine results in increased expression of CSNK1A1 protein] |
CTD |
PMID:28720477 |
|
NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions decreases expression |
ISO |
GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein] |
CTD |
PMID:28720477 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases metabolic processing |
ISO |
CYP1A1 protein results in increased metabolism of Quinacrine |
CTD |
PMID:16581945 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases expression |
EXP |
Quinacrine binds to and results in decreased activity of CYP2E1 protein Quinacrine results in decreased expression of CYP2E1 protein |
CTD |
PMID:18754103 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing |
ISO |
CYP3A4 protein results in increased metabolism of Quinacrine |
CTD |
PMID:16581945 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
increases metabolic processing |
ISO |
CYP3A5 protein results in increased metabolism of Quinacrine |
CTD |
PMID:16581945 |
|
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
|
|
G |
Foxp3 |
forkhead box P3 |
increases expression multiple interactions |
ISO |
Quinacrine results in increased expression of FOXP3 mRNA; Quinacrine results in increased expression of FOXP3 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of FOXP3 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of FOXP3 protein]; FOXP3 protein affects the reaction [Quinacrine results in decreased expression of BTRC protein]; FOXP3 protein affects the reaction [Quinacrine results in increased expression of MIR183 mRNA]; FOXP3 protein affects the reaction [Quinacrine results in increased expression of SP1 protein] |
CTD |
PMID:28867437 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Gli1 |
GLI family zinc finger 1 |
decreases expression multiple interactions |
ISO |
Quinacrine results in decreased expression of GLI1 protein GSK3B protein affects the reaction [Quinacrine results in decreased expression of GLI1 protein] |
CTD |
PMID:28720477 |
|
NCBI chr 7:63,156,926...63,169,579
Ensembl chr 7:63,156,926...63,169,251
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
increases expression multiple interactions |
ISO |
Quinacrine results in increased expression of GSK3B mRNA GSK3B protein affects the reaction [Quinacrine results in decreased expression of CCND1 protein]; GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein]; GSK3B protein affects the reaction [Quinacrine results in decreased expression of GLI1 protein]; GSK3B protein affects the reaction [Quinacrine results in decreased expression of MYC protein]; GSK3B protein affects the reaction [Quinacrine results in increased activity of CASP3 protein]; GSK3B protein affects the reaction [Quinacrine results in increased expression of CSNK1A1 protein]; Quinacrine results in increased expression of and results in decreased phosphorylation of GSK3B protein |
CTD |
PMID:28720477 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Quinacrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1A mRNA] |
CTD |
PMID:8435107 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
Quinacrine results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Kdr |
kinase insert domain receptor |
decreases phosphorylation |
ISO |
Quinacrine results in decreased phosphorylation of KDR protein |
CTD |
PMID:35724837 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
Quinacrine results in decreased phosphorylation of MAPK1 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK1 protein] |
CTD |
PMID:28867437 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation multiple interactions |
ISO |
Quinacrine results in decreased phosphorylation of MAPK3 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK3 protein] |
CTD |
PMID:28867437 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mir183 |
microRNA 183 |
multiple interactions increases expression |
ISO |
FOXP3 protein affects the reaction [Quinacrine results in increased expression of MIR183 mRNA]; MIR183 mRNA affects the reaction [Quinacrine results in decreased expression of BTRC protein]; MIR183 mRNA affects the reaction [Quinacrine results in increased expression of SP1 protein] |
CTD |
PMID:28867437 |
|
NCBI chr 4:58,788,614...58,788,723
Ensembl chr 4:58,788,614...58,788,723
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression multiple interactions |
ISO |
Quinacrine results in decreased expression of MYC protein GSK3B protein affects the reaction [Quinacrine results in decreased expression of MYC protein] |
CTD |
PMID:28720477 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nqo2 |
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
multiple interactions |
ISO |
Quinacrine binds to and results in decreased activity of NQO2 protein |
CTD |
PMID:15078100 |
|
NCBI chr17:30,909,482...30,938,725
Ensembl chr17:30,909,187...30,938,320
|
|
G |
Otc |
ornithine transcarbamylase |
multiple interactions |
EXP |
Quinacrine inhibits the reaction [PRL protein results in increased activity of OTC protein]; Quinacrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein] |
CTD |
PMID:3097147 |
|
NCBI chr X:12,453,834...12,529,954
Ensembl chr X:12,453,834...12,566,918
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Quinacrine results in increased cleavage of PARP1 protein |
CTD |
PMID:28867437 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
decreases phosphorylation |
ISO |
Quinacrine results in decreased phosphorylation of PLCG1 protein |
CTD |
PMID:35724837 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Prl |
prolactin |
multiple interactions |
EXP |
Quinacrine inhibits the reaction [PRL protein results in increased activity of OTC protein] |
CTD |
PMID:3097147 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
Quinacrine results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:35724837 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Sp1 |
Sp1 transcription factor |
multiple interactions |
ISO |
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of SP1 protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of SP1 protein]; FOXP3 protein affects the reaction [Quinacrine results in increased expression of SP1 protein]; MIR183 mRNA affects the reaction [Quinacrine results in increased expression of SP1 protein]; Quinacrine promotes the reaction [SP1 protein binds to BAX promoter]; Quinacrine results in increased expression of and results in increased stability of SP1 protein |
CTD |
PMID:28867437 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Tlr3 |
toll-like receptor 3 |
multiple interactions |
ISO |
Quinacrine inhibits the reaction [Poly I-C results in increased activity of TLR3 protein] |
CTD |
PMID:21398612 |
|
NCBI chr16:46,821,980...46,837,900
Ensembl chr16:46,822,039...46,836,545
|
|
G |
Tp53 |
tumor protein p53 |
increases activity multiple interactions affects activity |
ISO |
Quinacrine results in increased activity of TP53 protein Quinacrine results in increased stability of and results in increased activity of TP53 protein Quinacrine affects the activity of TP53 protein |
CTD |
PMID:12082016 PMID:16177561 PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|